← Back to Treatments
🏅 FDA Orphan Designation

Anavip

crotalidae immune F(ab')2 (equine)

Manufacturer: Rare Disease Therapeutics, Inc.

Indicated for:
OBSOLETE: Envenomization by Bothrops lanceolatusOrphanSnakebite envenomation

FDA-Approved Indications (2)

Management of adult and pediatric patients with North American rattlesnake envenomation

Management of adult and pediatric patients with North American rattlesnake envenomation

Population: adult and pediatric

Indications & Usage

Management of adult and pediatric patients with North American rattlesnake envenomation ||| For the management of adult and pediatric patients with North American Pit Viper envenomation

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.